Tovaxin News

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
NHE
Volunteer Moderator
Posts: 6221
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Tovaxin News

Post by NHE »

David McWilliams, CEO of PharmaFrontiers Corp, recently gave an interview with StreetIQ.com on August 25, 2005. The mp3 audio file of the interview can be found here. While the interview is targeted towards investors and not a scientific audience, there is still some very encouraging news none-the-less. During the interview, David McWilliams indicates that they are obtaining a 90% reduction in relapses! In addition, he states that 40% of their patients have improved physically with an improvement in disability scores ranging from 0.5 to 3 points on a 10 point scale within 6 months, and that the treatment is "stopping the progression of the disease!" 8O

NHE
User avatar
Arron
Volunteer Moderator
Posts: 902
Joined: Sun Feb 01, 2004 3:00 pm
Location: California, USA

Post by Arron »

excellent research and news! thanks for sharing :)
Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.
Post Reply

Return to “Drug Pipeline”